Advertisement
Screener

WINDTREE THERAPEUTICS INC /DE/ (WINT) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures

WINDTREE THERAPEUTICS INC /DE/ Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures

WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 0 shares for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.

Financial Statements › Shareholders' Equity

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2025-11-19

  • WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-09-30 was 0.00 shares.
  • WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-06-30 was 0.00 shares.
  • WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-03-31 was 0.00 shares.
  • WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2024-12-31 was 0.00 shares.
  • WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2024 was 0.00 shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month
2025-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19
0.00 shares
derived: sum of 2 quarters · filed 2025-11-19
0.00 shares
10-Q · filed 2025-11-19
0.00 shares
derived: sum of 4 quarters · filed 2025-11-19
2025-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19
0.00 shares
10-Q · filed 2025-08-19
0.00 shares
derived: sum of 3 quarters · filed 2025-08-19
0.00 shares
derived: sum of 4 quarters · filed 2025-11-19
2025-03-310.00 shares
10-Q · filed 2025-05-15
0.00 shares
derived: sum of 2 quarters · filed 2025-05-15
0.00 shares
derived: sum of 3 quarters · filed 2025-11-19
0.00 shares
derived: sum of 4 quarters · filed 2025-11-19
2024-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15
0.00 shares
derived: sum of 2 quarters · filed 2025-11-19
0.00 shares
derived: sum of 3 quarters · filed 2025-11-19
0.00 shares
10-K · filed 2025-04-15
2024-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19
0.00 shares
derived: sum of 2 quarters · filed 2025-11-19
0.00 shares
10-Q · filed 2025-11-19
2024-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19
0.00 shares
10-Q · filed 2025-08-19
2024-03-310.00 shares
10-Q · filed 2025-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
CURIS INC (CRIS)United States$0.002B-0.05
Silexion Therapeutics Corp (SLXN)$0.001B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70